Rexahn Pharmaceuticals Inc. has secured a new cancer patent that will further its efforts to develop cancer treatments.
The patent issued by the U.S. Patent & Trademark Office covers Rockville-based Rexahn’s cancer compound that may be effectively used for treating major solid tumors including drug-resistant tumors. It is the fourth patent in oncology.
